CHATTANOOGA, Tenn.--(BUSINESS WIRE)--Chattem, Inc. (NASDAQ: CHTT) – a leading marketer and manufacturer of branded consumer products, today announced the closing of its previously announced agreement to acquire the rights to ACT®, a branded over-the-counter (“OTC”) anti-cavity mouthwash/mouth rinse, in Western Europe together with worldwide trademark rights from Johnson & Johnson for $4.1 million in cash plus certain assumed liabilities. Chattem funded the acquisition with existing cash.
